IAVARONE, MASSIMO ALBERTO
IAVARONE, MASSIMO ALBERTO
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients
2007 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E. Del Ninno, M. Colombo
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients
2007 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E. Del Ninno, M. Colombo
A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene
2015 A. El Shamy, F.J. Eng, E.H. Doyle, A.L. Klepper, X. Sun, A. Sangiovanni, M. Iavarone, M. Colombo, R.E. Schwartz, Y. Hoshida, A.D. Branch
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration
2015 L.Y. King, C. Canasto Chibuque, K.B. Johnson, S. Yip, X. Chen, K. Kojima, M. Deshmukh, A. Venkatesh, P.S. Tan, X. Sun, A. Villanueva, A. Sangiovanni, V. Nair, M. Mahajan, M. Kobayashi, H. Kumada, M. Iavarone, M. Colombo, M.I. Fiel, S.L. Friedman, J.M. Llovet, R.T. Chung, Y. Hoshida
A prospective study of peripheral blood alpha-fetoprotein messenger RNA in cirrhotic patients at risk of hepatocellular carcinoma
2003 M. Iavarone, P. Lampertico, G. Ronchi, E. Del Ninno, A. Zanella, M. Colombo
Add on Adefovir prevents the emergence of ADV resistance in Lamivudine-resistant patients : a 4-year study
2008 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, M. Colombo
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine
2005 P. Lampertico, M. Viganò, E. Manenti, M.A. Iavarone, G. Lunghi, M. Colombo
An unprecedented challenge: The north italian gastroenterologist response to COVID-19
2022 G.E. Tontini, G. Aldinio, N. Nandi, A. Rimondi, D. Consonni, M. Iavarone, P. Cantu, A. Sangiovanni, P. Lampertico, M. Vecchi
Assessing tumor angiogenesis : Increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells
2004 C. Rabascio, E. Muratori, P. Mancuso, A. Calleri, V. Raia, T. Foutz, S. Cinieri, G. Veronesi, G. Pruneri, P. Lampertico, M.A. Iavarone, G. Martinelli, A. Goldhirsch, F. Bertolini
Chemoembolization with epirubicin drug eluting beads to treat early and intermediate hepatocellular carcinoma
2009 A. Nicolini, A. Sangiovanni, M. Iavarone, L. Martinetti, M.A. Manini, S. Crespi, M. Colombo
Cholangiocarcinoma in Cirrhosis : Value of Hepatocyte Specific Magnetic Resonance Imaging
2015 F. Piscaglia, M. Iavarone, M. Galassi, S. Vavassori, M. Renzulli, L.V. Forzenigo, A. Granito, V. Salvatore, A. Sangiovanni, R. Golfieri, M. Colombo, L. Bolondi
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B
2018 A. Loglio, M. Iavarone, G. Grossi, M. Viganò, M.G. Rumi, F. Facchetti, G. Lunghi, A. Sangiovanni, M. Colombo, P. Lampertico
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
2004 V. Di Marco, A. Marzano, P. Lampertico, P. Andreone, T. Santantonio, P.L. Almasio, M. Rizzetto, A. Craxì, G. Raimondo, G. Squadrito, A. Spadaro, O. Ferrah, T. Santantonio, G. Pastore, G. Niro, A. Andriulli, G. Stornaiolo, M. Stanzione, G.B. Gaeta, F. Piccinino, A. Marrone, G. Ruggiero, R. Ganga, M. Bernas coni, G. Pilleri, M. Brunetto, B. Coco, F. Bonino, G. Mazzella, F. Lodato, P. Andreone, C. Cursaro, s. Fiorino, A.G. Gramenzi, M. Massari, F. Torre, M. Basso, A. Picciotto, S. Targhetta, P. Burra, V. Ciappina, E. Mazzeffini, R. Bruno, S. Bruno, M. Vigano, M. Iavarone, E. Del Ninno, M. Colombo, A. Casella, M. Sonzogni, G. Colloredo, S. Rossi, M. Puoti, S. Gaia, V. Barbon, M. Lagget
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19
2020 M.A. Iavarone, R. D'Ambrosio, P. Lampertico
Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature
2021 E. Palomba, M. Maggioni, G. Viero, D. Mangioni, R. Lombardi, B. Antonelli, D. Dondossola, M. Iavarone, A.L. Fracanzani, A. Bandera, A. Gori, A. Lombardi, E. Palomba, M. Maggioni, G. Viero, D. Mangioni, R. Lombardi, B. Antonelli, D. Dondossola, M. Iavarone, A.L. Fracanzani, A. Bandera, A. Gori, A. Lombardi
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
2013 M. Iavarone, F. Piscaglia, S. Vavassori, M. Galassi, A. Sangiovanni, L. Venerandi, L.V. Forzenigo, R. Golfieri, L. Bolondi, M.G. Colombo
Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis
2013 M. Iavarone, M.A. Manini, A. Sangiovanni, M. Fraquelli, L.V. Forzenigo, L. Di Tommaso, A. Aghemo, M. Roncalli, G. Ronchi, M. Colombo
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
2013 C. Cammà, G. Cabibbo, S. Petta, M. Enea, M. Iavarone, A. Grieco, A. Gasbarrini, E. Villa, C. Zavaglia, R. Bruno, M. Colombo, A. Craxì
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib
2016 M. Iavarone, M. Primignani, S. Vavassori, A. Sangiovanni, V. La Mura, R. Romeo, M. Colombo
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma
2011 L. Di Tommaso, A. Destro, V. Fabbris, G. Spagnuolo, A. Laura Fracanzani, S. Fargion, M. Maggioni, C. Patriarca, R. Maria Macchi, M. Quagliuolo, M. Borzio, M. Iavarone, A. Sangiovanni, M. Colombo, M. Roncalli